Since the middle of the 20th century, antibiotics have been among the greatest successes in medicine. They save millions of ...

The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for ...

Entered into broad strategic collaboration with Eli Lilly and Company ('Lilly”) in the area of ophthalmology, granting Lilly worldwide exclusive rights to the Company’s AAV-AIPL1 program for treatment ...

From lab-grown "mini brains" to new findings on digital design and political persuasion, University scholars are expanding ...

The Oakland County school is one of 20 schools nationwide performing genetic research through a partnership with Stanford ...

Genome sequencing has been used to determine how much genes influence human characteristics including height and weight, and ...

Kygevvi (doxecitine and doxribtimine) earned FDA approval as the first treatment for thymidine kinase 2 deficiency, supported by data from a Phase II trial and multiple retrospective studies showing ...

Researchers at the University of California San Diego School of Medicine have developed a new approach for identifying ...

Cogent Biosciences, Inc. earns a Strong Buy rating due to positive phase 3 PEAK results for bezuclastinib + Sunitinib. Read ...

MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced a broad strategic collaboration ...

Next 10 years promises two Dell Medical School hospitals, more specialists advancing care, plus a focus on technology and ...